Effect of time delay in inter-hospital transfer on outcomes of endovascular treatment of acute ischemic stroke.

endovascular treatment ischemic stroke patient transfer thrombectomy time to treatment

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2023
Historique:
received: 27 09 2023
accepted: 05 12 2023
medline: 8 1 2024
pubmed: 8 1 2024
entrez: 8 1 2024
Statut: epublish

Résumé

Endovascular treatment (EVT) with mechanical thrombectomy is the standard of care for large vessel occlusion (LVO) in acute ischemic stroke (AIS). The most common approach today is to perform EVT in a comprehensive stroke center (CSC) and transfer relevant patients for EVT from a primary stroke center (PSC). Rapid and efficient treatment of LVO is a key factor in achieving a good clinical outcome. We present our retrospective cohort of patients who underwent EVT between 2018 and 2021, including direct admissions and patients transferred from PSC. Primary endpoints were time intervals (door-to-puncture, onset-to-puncture, door-to-door) and favorable outcome (mRS ≤ 2) at 90 days. Secondary outcomes were successful recanalization, mortality rate, and symptomatic intracranial hemorrhage (sICH). Additional analysis was performed for transferred patients not treated with EVT; endpoints were time intervals, favorable outcomes, and reason for exclusion of EVT. Among a total of 405 patients, 272 were admitted directly to our EVT center and 133 were transferred; there was no significant difference between groups in the occluded vascular territory, baseline NIHSS, wake-up strokes, or thrombolysis rate. Directly admitted patients had a shorter door-to-puncture time than transferred patients (190 min vs. 293 min, Our results show that transferring patients to the EVT center does not affect clinical outcomes, despite the expected delay in EVT. Reassessment of patients upon arrival at the CSC is crucial, and patient selection should be done based on both time and tissue window.

Sections du résumé

Background UNASSIGNED
Endovascular treatment (EVT) with mechanical thrombectomy is the standard of care for large vessel occlusion (LVO) in acute ischemic stroke (AIS). The most common approach today is to perform EVT in a comprehensive stroke center (CSC) and transfer relevant patients for EVT from a primary stroke center (PSC). Rapid and efficient treatment of LVO is a key factor in achieving a good clinical outcome.
Methods UNASSIGNED
We present our retrospective cohort of patients who underwent EVT between 2018 and 2021, including direct admissions and patients transferred from PSC. Primary endpoints were time intervals (door-to-puncture, onset-to-puncture, door-to-door) and favorable outcome (mRS ≤ 2) at 90 days. Secondary outcomes were successful recanalization, mortality rate, and symptomatic intracranial hemorrhage (sICH). Additional analysis was performed for transferred patients not treated with EVT; endpoints were time intervals, favorable outcomes, and reason for exclusion of EVT.
Results UNASSIGNED
Among a total of 405 patients, 272 were admitted directly to our EVT center and 133 were transferred; there was no significant difference between groups in the occluded vascular territory, baseline NIHSS, wake-up strokes, or thrombolysis rate. Directly admitted patients had a shorter door-to-puncture time than transferred patients (190 min vs. 293 min,
Conclusion UNASSIGNED
Our results show that transferring patients to the EVT center does not affect clinical outcomes, despite the expected delay in EVT. Reassessment of patients upon arrival at the CSC is crucial, and patient selection should be done based on both time and tissue window.

Identifiants

pubmed: 38187154
doi: 10.3389/fneur.2023.1303061
pmc: PMC10766796
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1303061

Informations de copyright

Copyright © 2023 Pardo, Naftali, Barnea, Findler, Perlow, Brauner, Auriel and Raphaeli.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Keshet Pardo (K)

Department of Neurology, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.
Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel.

Jonathan Naftali (J)

Department of Neurology, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.
Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel.

Rani Barnea (R)

Department of Neurology, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.
Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel.

Michael Findler (M)

Department of Neurology, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.
Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel.

Alain Perlow (A)

Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel.
Department of Radiology, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.

Ran Brauner (R)

Department of Neurology, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.
Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel.

Eitan Auriel (E)

Department of Neurology, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.
Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel.

Guy Raphaeli (G)

Department of Neurology, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.
Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel.

Classifications MeSH